{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:03:12Z","timestamp":1765609392899},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.06.020","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T17:52:36Z","timestamp":1221069156000},"page":"M89-M98","source":"Crossref","is-referenced-by-count":34,"special_numbering":"S12","title":["Recommendations for Cervical Cancer Prevention in Asia Pacific"],"prefix":"10.1016","volume":"26","author":[{"given":"Suzanne M.","family":"Garland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Cuzick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efren J.","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue J.","family":"Goldie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Tak","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Konno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Maxwell","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rengaswamy","family":"Sankaranarayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Kuie","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 12","key":"10.1016\/j.vaccine.2008.06.020_bib1","doi-asserted-by":"crossref","first-page":"M30","DOI":"10.1016\/j.vaccine.2008.05.006","article-title":"Human Papillomavirus Infection and Cervical Cancer Prevention in Japan and Korea","volume":"26","author":"Konno","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 12","key":"10.1016\/j.vaccine.2008.06.020_bib2","doi-asserted-by":"crossref","first-page":"M43","DOI":"10.1016\/j.vaccine.2008.05.005","article-title":"Human Papillomavirus Infection and Cervical Cancer Prevention in India, Bangladesh, Sri Lanka and Nepal","volume":"26","author":"Sankaranarayanan","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 12","key":"10.1016\/j.vaccine.2008.06.020_bib3","doi-asserted-by":"crossref","first-page":"M53","DOI":"10.1016\/j.vaccine.2008.05.009","article-title":"Epidemiology and Prevention of Human Papillomavirus and Cervical Cancer in China and Mongolia","volume":"26","author":"Shi","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 12","key":"10.1016\/j.vaccine.2008.06.020_bib4","first-page":"M60","article-title":"The Epidemiology of Human Papillomavirus Infection and Cervical Cancer and Future Perspectives in Hong Kong","volume":"26","author":"Tay","year":"2008","journal-title":"Singapore and Taiwan. Vaccine"},{"issue":"Suppl 12","key":"10.1016\/j.vaccine.2008.06.020_bib5","doi-asserted-by":"crossref","first-page":"M71","DOI":"10.1016\/j.vaccine.2008.05.039","article-title":"Epidemiology and Prevention of Cervical Cancer in Indonesia, Malaysia, Philippines, Thailand and Vietnam","volume":"26","author":"Domingo","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 12","key":"10.1016\/j.vaccine.2008.06.020_bib6","doi-asserted-by":"crossref","first-page":"M80","DOI":"10.1016\/j.vaccine.2008.05.041","article-title":"Human Papillomavirus and Cervical Cancer in Australasia and Oceania: Risk-factors, Epidemiology and Prevention","volume":"26","author":"Garland","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.020_bib7","unstructured":"United Nations (UN), Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2004 Revision. CD-ROM Edition - Extended Dataset. United Nations publications, Sales No. E.05.XIII.12. 2005."},{"key":"10.1016\/j.vaccine.2008.06.020_bib8","unstructured":"Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No.5, version 2.0 Lyon: IARC Press; 2004."},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.020_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.020_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1525-1438.2006.00460.x","article-title":"The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population","volume":"16","author":"Inoue","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.020_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.10825","article-title":"Prevalence of human papillomavirus infection in women in Busan, South Korea","volume":"103","author":"Shin","year":"2003","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.020_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3802\/kjgoc.2004.15.4.309","article-title":"Prevalence of human papillomavirus infection in Korean women: Risks of abnormal Pap smear and cervical neoplasia","volume":"15","author":"Joo","year":"2004","journal-title":"Korean J Gynecol Oncol Colpos"},{"key":"10.1016\/j.vaccine.2008.06.020_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-8-13","article-title":"Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study","volume":"8","author":"Oh","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.020_bib14","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.020_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6604262","article-title":"Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening","volume":"98","author":"Huang","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2008.06.020_bib16","unstructured":"Garland S, Brotherton J, Condon J, Tabrizi S, McIntyre P, Smith D, et al. Human Papillomavirus Genotype Prevalence In Australian Women (Indigenous, Non-indigenous, Urban, Rural Populations). LA-09. 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November 2007: LA-09."},{"issue":"Suppl. 12","key":"10.1016\/j.vaccine.2008.06.020_bib17","doi-asserted-by":"crossref","first-page":"M1","DOI":"10.1016\/j.vaccine.2008.05.010","article-title":"Burden and Trends of Type-specific Human Papillomavirus Infections and Related Diseases in the Asia-Pacific region","volume":"26","author":"Parkin","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.020_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1753-6405.2007.00146.x","article-title":"Estimates for cervical abnormalities in Vanuatu","volume":"31","author":"Fotinatos","year":"2007","journal-title":"Aust N Z J Public Health"},{"issue":"19","key":"10.1016\/j.vaccine.2008.06.020_bib19","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.vaccine.2008.06.020_bib20","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2008","journal-title":"N Engl J Med"},{"issue":"9580","key":"10.1016\/j.vaccine.2008.06.020_bib21","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.020_bib22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1467-842X.2000.tb01572.x","article-title":"Randomised controlled trial of an educational strategy to increase school-based adolescent hepatitis B vaccination","volume":"24","author":"Skinner","year":"2000","journal-title":"Aust N Z J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.020_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1300\/J013v45n02_04","article-title":"Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women","volume":"45","author":"Rosenthal","year":"2007","journal-title":"Women Health"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.020_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1071\/SH07023","article-title":"Knowledge and awareness of human papillomavirus (HPV): attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia","volume":"4","author":"Pitts","year":"2007","journal-title":"Sex Health"},{"key":"10.1016\/j.vaccine.2008.06.020_bib25","unstructured":"Shapiro C. WHO and Adolescent Immunization. Viral Hepatitis Prevention Board Meeting. March 2007. Ljubljana, Slovenia."},{"issue":"9447","key":"10.1016\/j.vaccine.2008.06.020_bib26","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.06.020_bib27","unstructured":"Brown D. First analysis of cross-protection against persistent infection, cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS) caused by oncogenic HPV types in addition to 16\/18. 47th Annual International Conference on Antimicrobial Agents and Chemotherapy. Chicago, USA, September 2007."},{"issue":"20","key":"10.1016\/j.vaccine.2008.06.020_bib28","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMp058171","article-title":"The promise of global cervical-cancer prevention","volume":"353","author":"Schiffman","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.020_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5694\/j.1326-5377.2008.tb01593.x","article-title":"Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26?","volume":"188","author":"Skinner","year":"2008","journal-title":"Med J Aust"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2008.06.020_bib30","doi-asserted-by":"crossref","first-page":"K87","DOI":"10.1016\/j.vaccine.2008.05.003","article-title":"Introduction of human papillomavirus vaccines into developing countries: international strategies for funding and procurement","volume":"26","author":"Andrus","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 12","key":"10.1016\/j.vaccine.2008.06.020_bib31","doi-asserted-by":"crossref","first-page":"M17","DOI":"10.1016\/j.vaccine.2008.06.018","article-title":"Mathematical models of cervical cancer prevention in the Asia Pacific Region","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.020_bib32","unstructured":"World Health Organization (WHO). Macroeconomics and health: investing in health for economic development: report of the commission on macroeconomics and health. Geneva: World Health Organization. 2001."},{"key":"10.1016\/j.vaccine.2008.06.020_bib33","unstructured":"World Health Organization (WHO) Statistical Information System: CHOICE (CHOosing Interventions that are Cost Effective). Available at: http:\/\/www.who.int\/choice\/en\/ (last accessed: April 2008)."},{"issue":"Suppl. 11","key":"10.1016\/j.vaccine.2008.06.020_bib34","doi-asserted-by":"crossref","first-page":"L59","DOI":"10.1016\/j.vaccine.2008.05.063","article-title":"Mathematical models of cervical cancer prevention in Latin America and the Caribbean","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2008.06.020_bib35","doi-asserted-by":"crossref","first-page":"K76","DOI":"10.1016\/j.vaccine.2008.06.009","article-title":"Modelling cervical cancer prevention in developed countries","volume":"26","author":"Kim","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:50:01Z","timestamp":1588917001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08007457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":35,"alternative-id":["S0264410X08007457"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}